Krishna Institute Of Medical Sciences Limited · NSE:KIMS
Krishna Institute Of Medical Sciences — Q4 FY26 Earnings Presentation
27 slides from Krishna Institute Of Medical Sciences's earnings presentation, May 15, 2026
Slide 1: Exchange filing cover letter: Investor Presentation
16th May 2026 The General Manager, The Manager, Department of Corporate Services Listing Department Bombay Stock Exchange Ltd (BSE) National Stock Exchange of India Limited, Phiroze Jheejheebhoy Towers, Exchange Plaza, 5th Floor, Dalal Street, Plot No.C/1, 'G' Block, Mumbai - 400 001. Bandra - Kurla
Slide 2: Investor Presentation
Investor Presentation May 15, 2026 Private & Confidential
Slide 3: Disclaimer
Disclaimer This presentation has been prepared by Krishna Institute of Medical Sciences Limited (the “Company”) solely for informational purposes. It should not be construed as an offer, solicitation, or recommendation to purchase or subscribe for any securities of the Company or its affiliates. The
Slide 4: Driven by a Vision
Driven by a Vision Affordable Quality Care VISION: Best-in-Class Facilities Patient Centric Systems & Processes S To be the most preferred NT healthcare services brand by TIE providing affordable care and best PA clinical outcomes to patients. Clinical Outcome Driven Excellence And to be the best pl
Slide 5: Multi Specialty Care
Multi Specialty Care Brain Eyes Bones and Spine Radiology • Neurology • Ophthalmology • Orthopedics • Imaging • Neurosurgery Gastro Intestinal Tract • Arthroscopic Surgery • Interventional Radiology • Psychiatry • Medical Gastroenterology • Spine Surgery Lab Services • Neuro Rehabilitation • Surgica
Slide 6: Dr. Bhaskara Rao Bollineni - Visionary Behind KIMS
Dr. Bhaskara Rao Bollineni - Visionary Behind KIMS Chairman & Managing Director A legend in CT Surgery, Dr. Bhaskara Rao Bollineni {MBBS, MS, DNB (CT Surgery)} is one of the very few Cardio-Thoracic Surgeons in the country, who performed over 30000 surgeries in his career spanning over more than 25
Slide 7: Dr. Abhinay Bollineni
Dr. Abhinay Bollineni Executive Director & CEO Dr. Abhinay Bollineni joined KIMS Hospitals in 2013 and spent the next couple of years in Hospital Operations before taking charge of Strategy & Marketing for the Group in 2015. He was appointed as the CEO in 2019. Dr. Abhinay Bollineni completed MBBS f
Slide 8: Board of Directors
Board of Directors Dr. Bhaskara Rao Bollineni Dr. Abhinay Bollineni Mrs. Anitha Dandamudi Mr. Saumen Chakraborty Chairman & Managing Director Executive Director & CEO Whole-time Director Independent Director, Chairman (Audit Committee) Mr. Adwik Bollineni Mr. Venkata Ramudu Jasthi Mrs. Y. Prameela R
Slide 9: Shareholding Pattern - As on 31 March, 2026
Shareholding Pattern - As on 31 March, 2026 st Retail & Others, Retail Pre IPO, 9.9% Top Institutional Share Holders 6.9% Share Holder Share Holding % Promoters, 34.1% SBI MF 5.9% HDFC MF 4.3% AXIS MF 4.3% FII, 16.4% Invesco MF 3.5% Kotak Fund 3.0% Nomura 2.9% Vanguard Equity Funds 2.4% Amansa Holdi
Slide 10: Modern Medical Technology
Modern Medical Technology 4-Arm HD da Vinci MrGFUS Focussed Tulsa-Pro System Robotic Surgical Ultrasound A non- invasive procedure that System Revolutionary Knifeless Brain uses real-time MRI guidance Facilitates complex surgeries procedure for treating tremors. to precisely deliver thermal that are
Slide 11: Many Firsts...
Many Firsts... • First in Asia to do Trans catheter • India’s first COVID Double Lung • Number 1 in Nephrology treatments in Tricuspid Valve replacement transplant done in 2020 Andhra Pradesh* procedure done in 2018 • India’s first Breathing Lung transplant • Number 1 in Neurosurgery & Poly • Larges
Slide 12: Key Accomplishments
Key Accomplishments NAL ACCRED TIO IT NA AT ER ION INT QU Y ET LI AF A TY & PAT I E N T S Pharmacie De Qualite (PDQ) American Accreditation Commission Certification Overall PDQ Evaluation ‘Patient Friendly Hospital’ NABH Digital Standards Accreditation Ranked No. 1 Hospital International (AACI) Perf
Slide 13: KIMS Journey: From Regional Leader to National Healthcare Roadmap
KIMS Journey: From Regional Leader to National Healthcare Roadmap Overall Bed Capacity of 8600+ Beds Year Andhra Pradesh Telangana Maharashtra Kerala Karnataka Tamil Nadu 2000 Nellore - 250 2001 Rajahmundry - 195 2004 Secunderabad - 1000 2011 Srikakulam - 300 2014 Kondapur - 220 2017 Ongole - 350 20
Slide 14: KIMS Journey: Strategic Levers for Future Growth
KIMS Journey: Strategic Levers for Future Growth Consistent Growth past 3 years Achieved 25%+ CAGR in Revenue and 13% CAGR in EBITDA, reflecting sustained operational excellence and strategic expansion. Delivering high-quality care through affordable healthcare models, advanced These transplant prog
Slide 15: FY26 Updates
FY26 Updates 14 Private & Confidential
Slide 16: Financial & Operational Highlights - 1/2
Financial & Operational Highlights - 1/2 (Rupees in Millions) Financial Highlights Particulars YoY YoY CAGR FY24 FY25 FY26 FY24 Vs FY25 (%) FY 25 Vs FY 26 (%) FY24 to FY26 (%) Operating Revenue 24,982 30,351 39,046 21.5% 28.6% 25.0% Other Income 161 319 262 98.3% (17.9%) 27.6% Total Revenue 25,143 3
Slide 17: Financial & Operational Highlights - 2/2
Financial & Operational Highlights - 2/2 Operational Highlights Particulars YoY YoY CAGR FY24 FY25 FY26 FY24 Vs FY25 (%) FY25 Vs FY26 (%) FY24 to FY26 (%) IP Voulme 1,91,167 2,13,346 2,46,297 11.6% 15.4% 13.5% OP Voulme 16,07,563 18,34,312 23,00,360 14.1% 25.4% 19.6% ARPOB (Rs) 31,916 39,158 44,644
Slide 18: Group Operating Performance
Group Operating Performance IP VOLUME (‘000) OP VOLUME (‘000) 15.4% 25.4% 246 2,300 213 191 1,834 1,608 FY24 FY25 FY26 FY24 FY25 FY26 OCCUPIED BEDS / OCCUPANCY % ARPOB (‘000) 9.0% 14.0% 2,450 44.6 2,248 39.2 2,148 31.9 61.3% 50.1% 50.5% FY24 FY25 FY26 FY24 FY25 FY26 “Bed Occupancy” means number of b
Slide 19: Group Operating and Financial Performance
Group Operating and Financial Performance Particulars FY24 FY25 FY26 Bed Capacity 3,975 5,179 6,464 Operational Beds 3,503 4,492 4,852 Occupied Beds 2,148 2,248 2,450 Occupancy 61.3% 50.1% 50.5% IP volume 1,91,167 2,13,346 2,46,297 OP volume 16,07,563 18,34,312 23,00,360 ARPOB(Rs.) 31,916 39,158 44,
Slide 20: Group Financial Performance
Group Financial Performance (Rupees in Millions) TOTAL REVENUE EBITDA 28.2% 1.6% 39,308 8,282 30,670 8,148 25,143 6,533 FY24 FY25 FY26 FY24 FY25 FY26 PBT PAT (40.2%) (41.7%) 5,581 4,148 3,359 4,595 2,420 3,339 FY24 FY25 FY26 FY24 FY25 FY26 “EBITDA” is equal to profit before tax plus depreciation plu
Slide 21: Operational and Financial Performance - 1/2
Operational and Financial Performance - 1/2 Telangana Andhra Pradesh Maharashtra Particulars FY24 FY25 FY26 FY24 FY25 FY26 FY24 FY25 FY26 Bed Capacity 1,727 1,797 1,882 1,914 2,214 2,314 334 659 959 Operational Beds 1,612 1,682 1,694 1,641 1,806 1,840 250 630 637 Occupied Beds 849 854 889 1,154 1,09
Slide 22: Operational and Financial Performance - 2/2
Operational and Financial Performance - 2/2 Kerala Karnataka Group Particulars FY25 FY26 FY26 FY24 FY25 FY26 Bed Capacity 509 509 800 3,975 5,179 6,464 Operational Beds 374 401 280 3,503 4,492 4,852 Occupied Beds 94 160 61 2,148 2,248 2,450 Occupancy** 25.2% 39.8% 21.6% 61.3% 50.1% 50.5% IP volume 5
Slide 23: Revenue Mix & Cluster Profile (Group FY26)
Revenue Mix & Cluster Profile (Group FY26) SPECIALITY MIX PAYOR MIX CLUSTER TOTAL REVENUE Kerala 4.4% Karnataka Maharashtra Aarogyasri 2.6% 11.8% 5% Others Cardiac Sciences 21% 17% Andhra Pradesh Corporate Cash 24.2 12% 53% Telangana 57.0% Renal Sciences 9% Mother & Child 10% Organ Oncology Transpla
Slide 24: Key Achievements in Q4 FY26
Key Achievements in Q4 FY26 23 Private & Confidential
Slide 25: Key Achievements in Q4 FY26
Key Achievements in Q4 FY26 24 Private & Confidential
Slide 26: Corporate Structure (As on 31 March 2026)
Corporate Structure (As on 31 March 2026) st Krishna Institute of Medical Sciences Limited Units Wholly Owned Subsidiaries KIMS Secunderabad KIMS Nellore KIMS Rajahmundry KIMS Ongole KIMS Thane KIMS QNRI KIMS Swastha KHPL (100%) (100%) (100%) (100%) (100%) Visakhapatnam Kerala Rajahmundry (100%) (10
Slide 27: Thank You
Thank You 26 Private & Confidential
Krishna Institute of Medical Sciences — Q4 FY26 Earnings Presentation on 6ix